Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

4-META resin heals skin wounds faster and better than cyanoacrylate.

Low-Level Laser Therapy can stimulate healing and cell function, potentially leading to wider medical use.

The book has valuable information but is hard to read due to poor writing.

The document concludes that while some advocate for a patient voucher system, it may be unequal and current healthcare reforms should be given a chance, and it also recommends various medical books for their comprehensive coverage and advice on specific health issues.

Skin issues can indicate immune system problems.

Advancements in tissue engineering show promise for hair follicle regeneration to treat hair loss.

Combining micro-needling, LED therapy, and growth factors with Finasteride® significantly improves hair growth.

Planarian regeneration begins with a specific gene activation caused by injury, essential for healing and tissue regrowth.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

HB-EGF boosts the hair growth ability of stem cells, making it a potential hair loss treatment.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Patients with hidradenitis suppurativa have higher levels of cell-free DNA in their blood.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Testosterone increases sexual behavior in female capuchin monkeys.

Minoxidil reduces lysine hydroxylase in skin cells.

Finasteride may affect PNMT, causing side effects.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

New treatments for male hypogonadism are effective and should be personalized.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Certain hormone treatments can improve acne and related conditions in women.

A new gene mutation causes insulin resistance in a girl and her mother.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.